Gail Sofer, BioPharm EAB Member, Retires from GE
Gail Sofer, a member of BioPharm International’s Editorial Advisory Board, has retired from her position as director of regulatory compliance at GE Healthcare.
Gail Sofer, a member of BioPharm International’s Editorial Advisory Board, has retired from her position as director of regulatory compliance at GE Healthcare. Sofer is a well-known figure in the biotechnology/biologics industry, where she worked for more than 26 years, most recently focusing on process development and validation and the designing in of regulatory compliance. In addition, she has taught courses on biotechnology for more than ten years and published extensively on downstream processing, virus inactivation, and validation, including co-editing and authoring several books. She continues to serve on the PDA Board of Directors, the PDA Biotech Advisory Board, and the EAB of BioPharm International. Following her retirement from GE Healthcare, Sofer plans to offer consulting services on biotechnology process validation.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.
